Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3675250
Max Phase: Preclinical
Molecular Formula: C18H24N4S2
Molecular Weight: 360.55
Molecule Type: Small molecule
Associated Items:
ID: ALA3675250
Max Phase: Preclinical
Molecular Formula: C18H24N4S2
Molecular Weight: 360.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C)CCCN1CCSc2cc(/N=C(\N)c3cccs3)ccc21
Standard InChI: InChI=1S/C18H24N4S2/c1-21(2)8-4-9-22-10-12-24-17-13-14(6-7-15(17)22)20-18(19)16-5-3-11-23-16/h3,5-7,11,13H,4,8-10,12H2,1-2H3,(H2,19,20)
Standard InChI Key: AIXCRSGMKMJRRJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 360.55 | Molecular Weight (Monoisotopic): 360.1442 | AlogP: 3.65 | #Rotatable Bonds: 6 |
Polar Surface Area: 44.86 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.52 | CX LogP: 3.24 | CX LogD: -0.09 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.63 | Np Likeness Score: -1.88 |
1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, |
Source(1):